KEAP1 and large cell neuroendocrine carcinoma: Rekhtman et al. performed an NGS analysis in 45 LCNEC and demonstrated alterations in TP53 (78%), RB1 (38%), STK11 (33%), KEAP1 (31%) and KRAS (22%) [46].